Clinical Trials on Liver Disease in New Zealand
Total 43812 results
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Alios Biopharma Inc.Completed
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Novartis PharmaceuticalsTerminated
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
Arrowhead PharmaceuticalsCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Antipodean Pharmaceuticals, Inc.Completed
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Arrowhead PharmaceuticalsTerminated
-
Assembly BiosciencesCompleted
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
AbbVieCompletedHepatic ImpairmentUnited States, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
University of ZurichUniversity Hospital, Strasbourg, France; University College London Hospitals; University Hospital, Essen and other collaboratorsCompletedNeoplasmsUnited Kingdom, Germany, Switzerland, United States, France, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Arena PharmaceuticalsTerminatedPrimary Biliary CholangitisUnited States, Australia, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Gilead SciencesCompletedHepatitis C | Cirrhosis | Portal Hypertension | With or Without Liver DecompensationUnited States, Spain, New Zealand, Australia, France
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Concord Repatriation General HospitalRecruitingHCC | Hepatocellular CarcinomaAustralia, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand